Drug recall · November 15, 2023
Synthroid recall
Why: Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
- Lots / codes
Lot # 1187435 exp date: 02/2024
- Quantity
- 864 cartons
- Company
- AbbVie Inc., North Chicago, IL
- Distribution
- Distributed in the US. No government or foreign consignees.
- Initiated
- October 17, 2023 · Voluntary: Firm initiated
- Classified
- November 5, 2023
- Reported
- November 15, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Synthroid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.